Indication
HIF-2 alpha erythrocytosis
1 clinical trial
1 product
Clinical trial
Phase 1 Study of Digoxin for Congenital Erythrocytosis Due to Up-Regulated Hypoxia SensingStatus: Withdrawn, Estimated PCD: 2024-12-31
Product
Digoxin1 clinical trial
1 product